Group B Streptococcus Clinical Trial
Official title:
The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center
NCT number | NCT01251289 |
Other study ID # | 09-072 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | December 2009 |
Est. completion date | September 2010 |
Verified date | December 2023 |
Source | Unity Health Toronto |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
A retrospective review of the prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center
Status | Completed |
Enrollment | 628 |
Est. completion date | September 2010 |
Est. primary completion date | September 2010 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - GBS positive pregnant women Exclusion Criteria: - n/a |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Unity Health Toronto |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04059510 -
Developing a Controlled Human Infection Model for Group B Streptococcus (CHIM_GBS)
|
||
Completed |
NCT01150123 -
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women
|
Phase 1 | |
Completed |
NCT02511444 -
Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor
|
N/A | |
Completed |
NCT00716781 -
Management of Infants Born to Group B Streptococcus Positive Mothers.
|
N/A | |
Completed |
NCT01982084 -
Group B Streptococcus: Attitudes to Immunisation in Pregnancy
|
||
Active, not recruiting |
NCT00972894 -
Group B Streptococcus (GBS) Polymerase Chain Reaction (PCR) Concordance Study
|
N/A | |
Terminated |
NCT00823433 -
Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood
|
Phase 0 | |
Completed |
NCT01180023 -
Membrane Sweeping in Group B Streptococcus (GBS) Positive Patients
|
N/A | |
Completed |
NCT00008853 -
Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines
|
Phase 1 |